Inhalational anthrax

Journal of Thoracic Imaging

Volumn 21, Issue 4, 2006, Pages 252-258

  Frazier, Aletta Ann ^a,b   Franks, Teri J ^a   Galvin, Jeffrey R ^a,b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bioterrorism; Hemorrhagic mediastinitis; Hyperdense lymph nodes on CT; Inhalational anthrax; Pleural effusions

Indexed keywords

ANTHRAX VACCINE; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; RIFAMPICIN;

ANTHRAX; ANTIBIOTIC THERAPY; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EXPOSURE; FLU LIKE SYNDROME; HISTOPATHOLOGY; HUMAN; LIFE CYCLE; MICROBIOLOGICAL EXAMINATION; MORTALITY; PATHOGENESIS; THORAX RADIOGRAPHY; VACCINATION;

ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BACTERIOLOGICAL TECHNIQUES; BIOTERRORISM; HUMANS; INHALATION EXPOSURE; UNITED STATES;

EID: 33751189148     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rti.0000213570.71161.84     Document Type: Conference Paper

References (37)

1. Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol. 1978;9:594-597.
2. Dixon TC, Meselson M, Guillemin J, et al. Anthrax. N Engl J Med. 1999;341:815-826.
3. Alibek K, Handelman S. Biohazard. New York, NY: Random House, Inc; 1999.
4. Guilleman J. Anthrax: The Investigation of a Deadly Outbreak. Berkeley and Los Angeles, California: University of California Press; 1999.
5. Cole L. The Anthrax Letters: A Medical Detective Story. Washington, DC: Joseph Henry Press; 2003.
6. Manchee RJ, Broster MG, Stagg AJ, et al. Formaldehyde solution effectively inactivates spores of Bacillus anthracis on the Scottish island of Gruinard. Appl Environ Microbiol. 1994;60:4167-4171.
7. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995;73:691-702.
8. Perl DP, Dooley JR. Anthrax. In: Binford CH, Connor DH, eds. Pathology of Tropical and Extraordinary Diseases. Washington, DC: Armed Forces Institute of Pathology; 1976:118-123.
9. Watson A, Keir D. Information on which to base assessments of risk from environments contaminated with anthrax spores. Epidemiol Infect. 1994;113:479-490.
10. Chensue SW. Exposing a killer: pathologists angle for anthrax. Am J Pathol. 2003;163:1699-1702.
11. Spencer RC. Bacillus anthracis. J Clin Pathol. 2003;56:182-187.
12. Watson A, Keir D. Information on which to base assessments of risk from environments contaminated with anthrax spores. Epidemiol Infect. 1994;113:479-490.
13. Guidi-Rontani C, Weber-Levy M, Labruyere E, et al. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol. 1999;31:9-17.
14. Swartz MN. Recognition and management of anthrax - an update. N Engl J Med. 2001;345:1621-1626.
15. Guarner J, Jernigan JA, Shieh WJ, et al. Inhalational Anthrax Pathology Working Group. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol. 2003;163:701-709.
16. Holty JE, Bravata DM, Liu H, et al. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006;144:270-280.
17. Centers for Disease Control and Prevention (CDC). Conference Summary: clinical issues in the prophylaxis, diagnosis and treatment of anthrax. Emerg Infect Dis. 2002;8:222-225.
18. Hanna P. Anthrax pathogenesis and host response. Curr Top Microbiol Immunol. 1998;225:13-35.
19. Hanna PC, Acosta D, Collier RJ. On the role of macrophages in anthrax. Proc Natl Acad Sci USA. 1993;90:10198-10201.
20. Little SF, Ivins BE. Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect. 1999;1:131-139.
21. Centers for Disease Control and Prevention (CDC). Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace. MMWR Morb Mortal Wkly Rep. 2004;53(No.RR-7):1-12.
22. Barakat LA, Quentzel HL, Jernigan JA, et al. Anthrax Bioterrorism Investigation Team. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:898-900.
23. Grinberg LM, Abramova FA, Yampolskaya OV, et al. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod Pathol. 2001;14:482-495.
24. Inglesby TV, O'Toole T, Henderson DA, et al. Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236-2252.
25. Mayer TA, Morrison A, Bersoff-Matcha S, et al. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001? Clin Infect Dis. 2003;36:1275-1283.
26. Douglas R. Chest roentgenograms in early diagnosis of infectious disease. Mil Med. 1963;104-109.
27. Quintiliani R Jr, Quintiliani R. Inhalational anthrax and bioterrorism. Curr Opin Pulm Med. 2003;9:221-226.
28. Hupert N, Bearman GM, Mushlin AI, et al. Accuracy of screening for inhalational anthrax after a bioterrorist attack. Ann Intern Med. 2003;139:337-345.
29. Vessal K, Yeganehdoust J, Dutz W, et al. Radiological changes in inhalation anthrax. A report of radiological and pathological correlation in two cases. Clin Radiol. 1975;26:471-474.
30. Earls JP, Cerva D Jr, Berman E, et al. Inhalational anthrax after bioterrorism exposure: spectrum of imaging findings in two surviving patients. Radiology. 2002;222:305-312.
31. Krol CM, Uszynski M, Dillon EH, et al. Dynamic CT features of inhalational anthrax infection. AJR Am J Roentgenol. 2002;178:1063-1066.
32. Wood BJ, DeFranco B, Ripple M, et al. Inhalational anthrax: radiologic and pathologic findings in two cases. AJR Am J Roentgenol. 2003;181:1071-1078.
33. Ketai L, Alrahji AA, Hart B, et al. Radiologic manifestations of potential bioterrorist agents of infection. AJR Am J Roentgenol. 2003;180:565-575.
34. Centers for Disease Control and Prevention (CDC). Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:941-948.
35. Cuneo BM. Inhalational anthrax. Respir Care Clin N Am. 2004;10:75-82.
36. Heddurshetti R, Pumpradit W, Lutwick LI. Pulmonary manifestations of bioterrorism. Curr Infect Dis Rep. 2001;3:249-257.
37. Wein LM, Craft DL, Kaplan EH. Emergency response to an anthrax attack. Proc Natl Acad Sci USA. 2003;100:4346-4351.